R. Nandagopal

881 total citations
31 papers, 605 citations indexed

About

R. Nandagopal is a scholar working on Molecular Biology, Accounting and Economics and Econometrics. According to data from OpenAlex, R. Nandagopal has authored 31 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Accounting and 4 papers in Economics and Econometrics. Recurrent topics in R. Nandagopal's work include Corporate Finance and Governance (3 papers), Innovation and Socioeconomic Development (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). R. Nandagopal is often cited by papers focused on Corporate Finance and Governance (3 papers), Innovation and Socioeconomic Development (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). R. Nandagopal collaborates with scholars based in United States, India and Canada. R. Nandagopal's co-authors include Paul B. Kaplowitz, Connie L. Davis, Annamaria T. Kausz, Katherine R. Tuttle, Neil K. Worrall, Priya Vaidyanathan, Rebecca J. Brown, Kristina I. Rother, Lillian R. Meacham and Daniel A. Mulrooney and has published in prestigious journals such as Scientific Reports, Annals of the New York Academy of Sciences and American Journal of Kidney Diseases.

In The Last Decade

R. Nandagopal

30 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Nandagopal United States 12 166 132 110 109 107 31 605
Roel E. Reddingius Netherlands 18 239 1.4× 141 1.1× 133 1.2× 180 1.7× 174 1.6× 33 908
Talat Mushtaq United Kingdom 14 216 1.3× 235 1.8× 80 0.7× 84 0.8× 26 0.2× 36 653
A. R. Al-Swailem Saudi Arabia 13 93 0.6× 91 0.7× 88 0.8× 127 1.2× 19 0.2× 32 728
Eric A. W. Slob United Kingdom 10 202 1.2× 88 0.7× 99 0.9× 81 0.7× 19 0.2× 21 872
R.J. Morgan United Kingdom 17 164 1.0× 173 1.3× 107 1.0× 68 0.6× 21 0.2× 58 1.0k
S. M. Gapstur United States 10 307 1.8× 126 1.0× 133 1.2× 50 0.5× 66 0.6× 11 1.0k
Yoo Seok Kim South Korea 13 56 0.3× 68 0.5× 133 1.2× 50 0.5× 37 0.3× 39 558
Shreekant Parasuraman United States 20 252 1.5× 127 1.0× 101 0.9× 31 0.3× 19 0.2× 68 974
Debbie Chen United States 15 276 1.7× 294 2.2× 174 1.6× 30 0.3× 24 0.2× 41 920
Akl C. Fahed United States 15 177 1.1× 91 0.7× 204 1.9× 41 0.4× 14 0.1× 43 935

Countries citing papers authored by R. Nandagopal

Since Specialization
Citations

This map shows the geographic impact of R. Nandagopal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Nandagopal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Nandagopal more than expected).

Fields of papers citing papers by R. Nandagopal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Nandagopal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Nandagopal. The network helps show where R. Nandagopal may publish in the future.

Co-authorship network of co-authors of R. Nandagopal

This figure shows the co-authorship network connecting the top 25 collaborators of R. Nandagopal. A scholar is included among the top collaborators of R. Nandagopal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Nandagopal. R. Nandagopal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khalil, Abdelouahed, et al.. (2025). Clinical, laboratory, radiological features, and outcome of acute fat embolism syndrome in sickle cell disease. Scientific Reports. 15(1). 27523–27523.
2.
Nandagopal, R., et al.. (2024). Impact of Masking Academic Metrics on Enrolling a Broadly Diverse and Mission-Aligned Student Body. Academic Medicine. 99(12). 1350–1355. 1 indexed citations
3.
Nandagopal, R., et al.. (2018). Sustainability Practices and Firm Performance in Small and Medium Sized Family Run Firms: A Generational Perspective. Journal of Management and Research. 18(2). 127–136. 6 indexed citations
4.
Nandagopal, R., et al.. (2018). Sustainable Development Practices Adopted by SMEs in a Developing Economy: An Empirical Study. SSRN Electronic Journal. 17(3). 7. 5 indexed citations
5.
Nandagopal, R., et al.. (2016). From Multi-Channel to Omni-Channel: Determinants of Channel Choice. Asian Journal of Research in Social Sciences and Humanities. 6(9). 1016–1016. 3 indexed citations
6.
Nguyen, Tammy, Giovanni Cizza, Rebecca J. Brown, et al.. (2013). Challenging Recruitment of Youth With Type 2 Diabetes Into Clinical Trials. Journal of Adolescent Health. 54(3). 247–254. 44 indexed citations
7.
Kannadhasan, M. & R. Nandagopal. (2011). Firm Size as a Moderator of the Relationship between Business Strategy and Performance in Indian Automotive Industry. SSRN Electronic Journal. 4 indexed citations
8.
Nandagopal, R., Ninet Sinaii, Nilo A. Avila, et al.. (2011). Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families. European Journal of Endocrinology. 164(6). 977–984. 51 indexed citations
9.
Nandagopal, R., et al.. (2011). Disclosure Studies – A Commentary on the Methods and Measures. RePEc: Research Papers in Economics. 4(1). 29–46. 6 indexed citations
10.
Kannadhasan, M. & R. Nandagopal. (2010). Do Company-Specific Factors Influence the Extent of Usage of Risk Analysis Techniques in Strategic Investment Decisions?. SSRN Electronic Journal. 8 indexed citations
11.
Brown, Rebecca J., et al.. (2010). Clinical trials in youth with type 2 diabetes. Pediatric Diabetes. 12(1). 50–57. 12 indexed citations
12.
Solomon, Benjamin D., Daniel Pineda‐Alvarez, Joan Z. Balog, et al.. (2009). Compound heterozygosity for mutations in PAX6 in a patient with complex brain anomaly, neonatal diabetes mellitus, and microophthalmia. American Journal of Medical Genetics Part A. 149A(11). 2543–2546. 73 indexed citations
13.
Nandagopal, R., Priya Vaidyanathan, & Paul B. Kaplowitz. (2009). Transient Pseudohypoaldosteronism due to Urinary Tract Infection in Infancy: A Report of 4 Cases. International Journal of Pediatric Endocrinology. 2009. 1–4. 33 indexed citations
14.
Shobha, Nandavar, Anita Mahadevan, Arun B. Taly, et al.. (2008). Hypertrophic cranial pachymeningitis in countries endemic for tuberculosis: Diagnostic and therapeutic dilemmas. Journal of Clinical Neuroscience. 15(4). 418–427. 17 indexed citations
15.
Covington, Sharon N., Pedro E. Martinez, Vaishali Popat, et al.. (2008). The Psychology of Antecedents to Adult Reproductive Disorders in Adolescent Girls. Annals of the New York Academy of Sciences. 1135(1). 155–162. 8 indexed citations
16.
Nandagopal, R., Caroline Laverdière, Daniel A. Mulrooney, Melissa M. Hudson, & Lillian R. Meacham. (2007). Endocrine Late Effects of Childhood Cancer Therapy: A Report from the Children’s Oncology Group. Hormone Research in Paediatrics. 69(2). 65–74. 87 indexed citations
17.
Nandagopal, R., et al.. (2005). Awareness on Consumer Finance in Rural Market: An Analysis. Indian Journal of Marketing. 35(1). 1 indexed citations
18.
Nandagopal, R., et al.. (2004). Transient mutism due to posterior circulation infarction.. PubMed. 52(4). 510–1. 5 indexed citations
19.
Tuttle, Katherine R., et al.. (2002). Predictors of ARF after cardiac surgical procedures. American Journal of Kidney Diseases. 41(1). 76–83. 126 indexed citations
20.
Nandagopal, R., et al.. (1989). State Level Public Enterprises in India-An Overview. Economic and political weekly. 24(8). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026